In today’s #readoftheweek📚 learn why accurate quantification of alcohol intake is crucial in the clinical phenotyping of patients with #steatoticliverdisease & when designing clinical trials.
Read now: www.jhep-reports.eu/article/S258...
🙏 @aleksanderkrag.bsky.social @majathiele.bsky.social et al.
Read now: www.jhep-reports.eu/article/S258...
🙏 @aleksanderkrag.bsky.social @majathiele.bsky.social et al.
February 5, 2025 at 1:33 PM
In today’s #readoftheweek📚 learn why accurate quantification of alcohol intake is crucial in the clinical phenotyping of patients with #steatoticliverdisease & when designing clinical trials.
Read now: www.jhep-reports.eu/article/S258...
🙏 @aleksanderkrag.bsky.social @majathiele.bsky.social et al.
Read now: www.jhep-reports.eu/article/S258...
🙏 @aleksanderkrag.bsky.social @majathiele.bsky.social et al.
@imperialcollegeldn.bsky.social, @who.int and @easlnews.bsky.social have launched first WHO Collaborating Centre dedicated to #liver disease.
@britishlivertrust.bsky.social #LiverDisease #SteatoticLiverDisease
www.imperial.ac.uk/news/article...
@britishlivertrust.bsky.social #LiverDisease #SteatoticLiverDisease
www.imperial.ac.uk/news/article...
Imperial, WHO and EASL launch first WHO Collaborating Centre dedicated to liver disease
Imperial, the World Health Organization (WHO) Regional Office for Europe, and the European Association for the Study of the Liver (EASL) have launche...
www.imperial.ac.uk
June 25, 2026 at 9:30 AM
@imperialcollegeldn.bsky.social, @who.int and @easlnews.bsky.social have launched first WHO Collaborating Centre dedicated to #liver disease.
@britishlivertrust.bsky.social #LiverDisease #SteatoticLiverDisease
www.imperial.ac.uk/news/article...
@britishlivertrust.bsky.social #LiverDisease #SteatoticLiverDisease
www.imperial.ac.uk/news/article...
Disease stage vs. cause of #liverf="/hashtag/liverdisease" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#liverdisease
A study led by #MedUniVienna shows that, in advanced #SteatoticLiverDisease, it is primarily the increased pressure in the #liver’s blood circulation that determines the risk of serious complications.
Find out more! ⬇️
📰 @aga-cgh.bsky.social
A study led by #MedUniVienna shows that, in advanced #SteatoticLiverDisease, it is primarily the increased pressure in the #liver’s blood circulation that determines the risk of serious complications.
Find out more! ⬇️
📰 @aga-cgh.bsky.social
Fatty Liver: Pressure in the Hepatic Circulation Indicates a Risk of Severe Complications
More about the findings!
www.meduniwien.ac.at
June 25, 2026 at 12:09 PM
Disease stage vs. cause of #liverf="/hashtag/liverdisease" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#liverdisease
A study led by #MedUniVienna shows that, in advanced #SteatoticLiverDisease, it is primarily the increased pressure in the #liver’s blood circulation that determines the risk of serious complications.
Find out more! ⬇️
📰 @aga-cgh.bsky.social
A study led by #MedUniVienna shows that, in advanced #SteatoticLiverDisease, it is primarily the increased pressure in the #liver’s blood circulation that determines the risk of serious complications.
Find out more! ⬇️
📰 @aga-cgh.bsky.social
📋 Revisiting our joint position statement on steatotic liver disease (SLD).
Endorsed by 50+ global partners, calling for SLD to be recognised within NCD strategies: https://ow.ly/IhfP50ZPcgx
#LiverHealth #SteatoticLiverDisease #NCDs
Endorsed by 50+ global partners, calling for SLD to be recognised within NCD strategies: https://ow.ly/IhfP50ZPcgx
#LiverHealth #SteatoticLiverDisease #NCDs
September 24, 2026 at 7:00 AM
📋 Revisiting our joint position statement on steatotic liver disease (SLD).
Endorsed by 50+ global partners, calling for SLD to be recognised within NCD strategies: https://ow.ly/IhfP50ZPcgx
#LiverHealth #SteatoticLiverDisease #NCDs
Endorsed by 50+ global partners, calling for SLD to be recognised within NCD strategies: https://ow.ly/IhfP50ZPcgx
#LiverHealth #SteatoticLiverDisease #NCDs
New review highlights critical gaps in pediatric steatotic liver disease: over-reliance on liver tests, generic lifestyle advice & under-treated advanced cases.
#Meded #SoMe4PedSurg #FattyLiver #SteatoticLiverDisease #MASLD #NAFLD #Pediatrics
link.springer.com/article/10.1...
#Meded #SoMe4PedSurg #FattyLiver #SteatoticLiverDisease #MASLD #NAFLD #Pediatrics
link.springer.com/article/10.1...
April 21, 2025 at 6:31 AM
New review highlights critical gaps in pediatric steatotic liver disease: over-reliance on liver tests, generic lifestyle advice & under-treated advanced cases.
#Meded #SoMe4PedSurg #FattyLiver #SteatoticLiverDisease #MASLD #NAFLD #Pediatrics
link.springer.com/article/10.1...
#Meded #SoMe4PedSurg #FattyLiver #SteatoticLiverDisease #MASLD #NAFLD #Pediatrics
link.springer.com/article/10.1...
New article to read! Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals.
➡️ SLD is an independent predictor for long-term mortality in heavy smokers
🔗 doi.org/10.1111/joim...
#steatoticliverdisease #lungcancer #SLD
➡️ SLD is an independent predictor for long-term mortality in heavy smokers
🔗 doi.org/10.1111/joim...
#steatoticliverdisease #lungcancer #SLD
January 28, 2025 at 3:11 PM
New article to read! Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals.
➡️ SLD is an independent predictor for long-term mortality in heavy smokers
🔗 doi.org/10.1111/joim...
#steatoticliverdisease #lungcancer #SLD
➡️ SLD is an independent predictor for long-term mortality in heavy smokers
🔗 doi.org/10.1111/joim...
#steatoticliverdisease #lungcancer #SLD
📊 Did you know? SLD affects an estimated 1.7 billion people worldwide, making it the fastest-growing cause of chronic liver disease globally.
🔗Read our position statement: https://ow.ly/Kk2Z50ZPcjB
#LiverHealth #SteatoticLiverDisease #NCDs
🔗Read our position statement: https://ow.ly/Kk2Z50ZPcjB
#LiverHealth #SteatoticLiverDisease #NCDs
New global position statement calls for action on steatotic liver disease (SLD) within the NCD response | World Obesity Federation
World Obesity join global partners in endorsing call for the adoption of a World Health Assembly resolution on SLD
ow.ly
September 24, 2026 at 10:00 AM
📊 Did you know? SLD affects an estimated 1.7 billion people worldwide, making it the fastest-growing cause of chronic liver disease globally.
🔗Read our position statement: https://ow.ly/Kk2Z50ZPcjB
#LiverHealth #SteatoticLiverDisease #NCDs
🔗Read our position statement: https://ow.ly/Kk2Z50ZPcjB
#LiverHealth #SteatoticLiverDisease #NCDs
In more than 850 000 adults with #SteatoticLiverDisease, the steatosis-associated fibrosis estimator (SAFE) score provided the greatest net benefit for identifying 10-year cirrhosis risk and may help guide repeat surveillance. ja.ma/4xGTuBh
September 21, 2026 at 3:30 PM
In more than 850 000 adults with #SteatoticLiverDisease, the steatosis-associated fibrosis estimator (SAFE) score provided the greatest net benefit for identifying 10-year cirrhosis risk and may help guide repeat surveillance. ja.ma/4xGTuBh
We hope you'll be at the 2026 CASL Single Topic Conference on Steatotic Liver Disease in Montreal, September 18-19. Looking forward to connecting with the Canadian liver health community.
Learn more: caslstc.ca
#CASLSTC2026 #SteatoticLiverDisease #MASLD #Hepatology
Learn more: caslstc.ca
#CASLSTC2026 #SteatoticLiverDisease #MASLD #Hepatology
September 10, 2026 at 3:34 PM
We hope you'll be at the 2026 CASL Single Topic Conference on Steatotic Liver Disease in Montreal, September 18-19. Looking forward to connecting with the Canadian liver health community.
Learn more: caslstc.ca
#CASLSTC2026 #SteatoticLiverDisease #MASLD #Hepatology
Learn more: caslstc.ca
#CASLSTC2026 #SteatoticLiverDisease #MASLD #Hepatology
#SteatoticLiverDisease is a common but underrecognized complication after pancreaticoduodenectomy.
https://www.gastroenterologyadvisor.com/news/steatotic-liver-disease-common-after-pancreaticoduodenectomy/
https://www.gastroenterologyadvisor.com/news/steatotic-liver-disease-common-after-pancreaticoduodenectomy/
Steatotic Liver Disease Develops in Over 25% of Adults Postpancreaticoduodenectomy
Approximately a quarter of patients develop steatotic liver disease following pancreaticoduodenectomy.
www.gastroenterologyadvisor.com
April 24, 2026 at 4:50 AM
#SteatoticLiverDisease is a common but underrecognized complication after pancreaticoduodenectomy.
https://www.gastroenterologyadvisor.com/news/steatotic-liver-disease-common-after-pancreaticoduodenectomy/
https://www.gastroenterologyadvisor.com/news/steatotic-liver-disease-common-after-pancreaticoduodenectomy/
#virology #ViiVHealthcare #steatoticliverdisease #Dovato #2drugHIVregimens #3drugHIVregimens #PASODOBLEstudy #HIV1 #HIV #Biktarvy #ConferenceonRetrovirusesandOpportunisticInfections2026 #HIVinnovation #metabolichealthoutcome #longtermHIVtreatment
zurl.co/ESlts
zurl.co/ESlts
ViiV Healthcare data show lower rates of steatotic liver disease after switching to Dovato - PharmaTimes
PASO DOBLE sub‑analysis indicates metabolic differences between 2‑drug and 3‑drug HIV regimens
pharmatimes.com
March 3, 2026 at 9:57 AM
We are one week away from @ohioliver and @LiverCoalition's joint roundtable webinar!
On August 2nd, join our expert panel @DCPatient, @DrLoomba, and @AlkhouriNaim for this timely topic.
Register at http://tinyurl.com/Liver2023
#liverhealth #fattyliverdisease #steatoticliverdisease
On August 2nd, join our expert panel @DCPatient, @DrLoomba, and @AlkhouriNaim for this timely topic.
Register at http://tinyurl.com/Liver2023
#liverhealth #fattyliverdisease #steatoticliverdisease
March 22, 2025 at 5:22 AM
We are one week away from @ohioliver and @LiverCoalition's joint roundtable webinar!
On August 2nd, join our expert panel @DCPatient, @DrLoomba, and @AlkhouriNaim for this timely topic.
Register at http://tinyurl.com/Liver2023
#liverhealth #fattyliverdisease #steatoticliverdisease
On August 2nd, join our expert panel @DCPatient, @DrLoomba, and @AlkhouriNaim for this timely topic.
Register at http://tinyurl.com/Liver2023
#liverhealth #fattyliverdisease #steatoticliverdisease
📢 Review in #LiversMDPI
🧬 Compares #MASLD in humans & mice, highlighting genetics, lifestyle & diet as key drivers
🩺 Histology remains essential for staging, while non-invasive imaging emerges as complementary
📖Read more: www.mdpi.com/2673-4389/6/...
#MouseModels #SteatoticLiverDisease
🧬 Compares #MASLD in humans & mice, highlighting genetics, lifestyle & diet as key drivers
🩺 Histology remains essential for staging, while non-invasive imaging emerges as complementary
📖Read more: www.mdpi.com/2673-4389/6/...
#MouseModels #SteatoticLiverDisease
July 6, 2026 at 11:04 AM
📢 Review in #LiversMDPI
🧬 Compares #MASLD in humans & mice, highlighting genetics, lifestyle & diet as key drivers
🩺 Histology remains essential for staging, while non-invasive imaging emerges as complementary
📖Read more: www.mdpi.com/2673-4389/6/...
#MouseModels #SteatoticLiverDisease
🧬 Compares #MASLD in humans & mice, highlighting genetics, lifestyle & diet as key drivers
🩺 Histology remains essential for staging, while non-invasive imaging emerges as complementary
📖Read more: www.mdpi.com/2673-4389/6/...
#MouseModels #SteatoticLiverDisease
Tirzepatide shows promise in alleviating metabolic dysfunction-associated steatotic liver disease, supporting its potential as a treatment for metabolic liver disorders.
www.sciencedirect.com/science/arti...
#Tirzepatide #MASLD #MetabolicDysfunction #SteatoticLiverDisease #MetabolicHealth
www.sciencedirect.com/science/arti...
#Tirzepatide #MASLD #MetabolicDysfunction #SteatoticLiverDisease #MetabolicHealth
June 30, 2026 at 8:29 AM
Tirzepatide shows promise in alleviating metabolic dysfunction-associated steatotic liver disease, supporting its potential as a treatment for metabolic liver disorders.
www.sciencedirect.com/science/arti...
#Tirzepatide #MASLD #MetabolicDysfunction #SteatoticLiverDisease #MetabolicHealth
www.sciencedirect.com/science/arti...
#Tirzepatide #MASLD #MetabolicDysfunction #SteatoticLiverDisease #MetabolicHealth